From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA expands use of MS drug to include children

from HealthDay News via Clinical Advisor

The U.S. Food and Drug Administration has expanded its approval of the multiple sclerosis drug Gilenya (fingolimod) to include children aged 10 and older. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063